The DOI matches its Crossref record; 687 of the 687 references it cites were found in a registry or an index.
Pharmacology of Heparin and Related Drugs
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–400 of 687
DeLisser, H. M., Yan, H. C., Newman, P. J., Muller, W. A., Buck, C. A., & Albelda, S. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82354-7 · Cited by 180
STUDIES ON THE CHEMISTRY OF BLOOD COAGULATION
Chargaff, E., & Olson, K. B. (1937) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)74257-9 · Cited by 178
Centola, M., Rainer, A., Spadaccio, C., De Porcellinis, S., Genovese, J. A., & Trombetta, M. (2010) · Biofabrication · doi:10.1088/1758-5082/2/1/014102 · Cited by 177
Robinson, C. J., Mulloy, B., Gallagher, J. T., & Stringer, S. E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510760200 · Cited by 175
Self-citationNon-Anticoagulant Heparins and Inhibition of Cancer
Casu, B., Vlodavsky, I., & Sanderson, R. D. (2007) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000175157 · Cited by 174
Structural Impact of Heparin Binding to Full-Length Tau As Studied by NMR Spectroscopy
Sibille, N., Sillen, A., Leroy, A., Wieruszeski, J.-M., Mulloy, B., Landrieu, I., & Lippens, G. (2006) · Biochemistry · doi:10.1021/bi060964o · Cited by 174
Self-citationHeparin and low-molecular weight heparins
Hirsh, J. (1992) · Coronary Artery Disease · doi:10.1097/00019501-199211000-00002 · Cited by 174
Johnson, D. J., Li, W., Adams, T. E., & Huntington, J. A. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601089 · Cited by 173
Carrier, M., Cameron, C., Delluc, A., Castellucci, L., Khorana, A. A., & Lee, A. Y. Y. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.09.039 · Cited by 172
The Purification of a Lipoprotein Lipase from Bovine Skim Milk
Egelrud, T., & Olivecrona, T. (1972) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)44784-4 · Cited by 171
Muir, J. M., Hirsh, J., Weitz, J. I., Andrew, M., Young, E., & Shaughnessy, S. G. (1997) · Blood · doi:10.1182/blood.v89.9.3236 · Cited by 171
Structural and Functional Basis of CXCL12 (Stromal Cell-derived Factor-1α) Binding to Heparin
Murphy, J. W., Cho, Y., Sachpatzidis, A., Fan, C., Hodsdon, M. E., & Lolis, E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608796200 · Cited by 170
Disruption of sulphated glycosaminoglycans in intestinal inflammation
Murch, S. H., MacDonald, T. T., Walker-Smith, J. A., Lionetti, P., Levin, M., & Klein, N. J. (1993) · The Lancet · doi:10.1016/0140-6736(93)90485-y · Cited by 170
Bachelet, L., Bertholon, I., Lavigne, D., Vassy, R., Jandrot-Perrus, M., Chaubet, F., & Letourneur, D. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.10.008 · Cited by 170
Alikhan, R., Forster, R., & Cohen, A. T. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003747.pub4 · Cited by 169
Liu, J., Shriver, Z., Pope, R. M., Thorp, S. C., Duncan, M. B., Copeland, R. J., Raska, C. S., Yoshida, K., Eisenberg, R. J., Cohen, G., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202034200 · Cited by 169
Lim, W., Cook, D. J., & Crowther, M. A. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000145014.80714.35 · Cited by 168
Characterization of the Heparin-Binding Properties of IL-6
Mummery, R. S., & Rider, C. C. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.10.5671 · Cited by 167
Platelet Factor 4: Production, Structure, and Physiologic and Immunologic Action
Zucker, M. B., & Katz, I. R. (1991) · Experimental Biology and Medicine · doi:10.3181/00379727-198-43309 · Cited by 167
Placental transport of heparin
Flessa, H. C., Kapstrom, A. B., Glueck, H. I., & Will, J. J. (1965) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(65)90518-1 · Cited by 165
Lee, J., Yoo, J. J., Atala, A., & Lee, S. J. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.06.017 · Cited by 164
Profiling Heparin–Chemokine Interactions Using Synthetic Tools
de Paz, J. L., Moseman, E. A., Noti, C., Polito, L., von Andrian, U. H., & Seeberger, P. H. (2007) · ACS Chemical Biology · doi:10.1021/cb700159m · Cited by 164
Johnson, Z., Kosco‐Vilbois, M. H., Herren, S., Cirillo, R., Muzio, V., Zaratin, P., Carbonatto, M., Mack, M., Smailbegovic, A., Rose, M., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.9.5776 · Cited by 164
Self-citationJoyce, J. A., Freeman, C., Meyer-Morse, N., Parish, C. R., & Hanahan, D. (2005) · Oncogene · doi:10.1038/sj.onc.1208602 · Cited by 163
Yu, J., Wang, A., Tang, Z., Henry, J., Li-Ping Lee, B., Zhu, Y., Yuan, F., Huang, F., & Li, S. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.07.042 · Cited by 162
Ruvinov, E., Leor, J., & Cohen, S. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.02.026 · Cited by 162
Crystal Structure of Thrombin Bound to Heparin
Carter, W. J., Cama, E., & Huntington, J. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411606200 · Cited by 162
Greinacher, A., Gopinadhan, M., Günther, J.-U., Omer-Adam, M. A., Strobel, U., Warkentin, T. E., Papastavrou, G., Weitschies, W., & Helm, C. A. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000238350.89477.88 · Cited by 161
The role of extracellular Tau in the spreading of neurofibrillary pathology
Medina, M., & Avila, J. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00113 · Cited by 161
Boehlen, F., & Clemetson, K. J. (2001) · Transfusion Medicine · doi:10.1046/j.1365-3148.2001.00340.x · Cited by 159
DeAngelis, P. L., Liu, J., & Linhardt, R. J. (2013) · Glycobiology · doi:10.1093/glycob/cwt016 · Cited by 159
Mohammadi, M., Olsen, S. K., & Goetz, R. (2005) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2005.09.002 · Cited by 158
Deep vein thrombosis in cancer: the scale of the problem and approaches to management
Falanga, A., & Zacharski, L. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi165 · Cited by 158
Conformational changes and anticoagulant activity of chondroitin sulfate following its O-sulfonation
Maruyama, T., Toida, T., Imanari, T., Yu, G., & Linhardt, R. J. (1998) · Carbohydrate Research · doi:10.1016/s0008-6215(97)10060-x · Cited by 158
Watt, S., Williamson, J., Genevier, H., Fawcett, J., Simmons, D., Hatzfeld, A., Nesbitt, S., & Coombe, D. (1993) · Blood · doi:10.1182/blood.v82.9.2649.2649 · Cited by 158
The heparin-binding growth factor midkine: the biological activities and candidate receptors
Kadomatsu, K., Kishida, S., & Tsubota, S. (2013) · The Journal of Biochemistry · doi:10.1093/jb/mvt035 · Cited by 155
Mechanisms of glycosaminoglycan activation of the serpins in hemostasis
Huntington, J. A. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00305.x · Cited by 153
The risks of antenatal subcutaneous heparin prophylaxis: a controlled trial
Howell, R. J. S., Fidler, J., Letsky, E. A., & de Swiet, M. (1983) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1983.tb06458.x · Cited by 153
Lider, O., Mekori, Y. A., Miller, T. B., et al. (1990) · European Journal of Immunology · doi:10.1002/eji.1830200306 · Cited by 153
The effects of low molecular weight and standard heparin on calcium loss from fetal rat calvaria
Shaughnessy, S., Young, E., Deschamps, P., et al. (1995) · Blood · doi:10.1182/blood.v86.4.1368.bloodjournal8641368 · Cited by 152
Miyamoto, K., Asada, K., Fukutomi, T., Okochi, E., Yagi, Y., Hasegawa, T., Asahara, T., Sügimura, T., & Ushijima, T. (2003) · Oncogene · doi:10.1038/sj.onc.1206146 · Cited by 152
Ostrovsky, O., Berman, B., Gallagher, J., Mulloy, B., Fernig, D., Delehedde, M., & Ron, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108540200 · Cited by 152
Self-citationClark, S. J., Ridge, L. A., Herbert, A. P., Hakobyan, S., Mulloy, B., Lennon, R., Würzner, R., Morgan, B. P., Uhrín, D., Bishop, P. N., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201751 · Cited by 152
Self-citationBar-Ner, M., Eldor, A., Wasserman, L., et al. (1987) · Blood · doi:10.1182/blood.v70.2.551.551 · Cited by 151
Salem, C. B., Badreddine, A., Fathallah, N., Slim, R., & Hmouda, H. (2014) · Drug Safety · doi:10.1007/s40264-014-0196-1 · Cited by 151
A strategy for rapid sequencing of heparan sulfate and heparin saccharides
Turnbull, J. E., Hopwood, J. J., & Gallagher, J. T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.2698 · Cited by 151
Histomorphometric analysis of the effects of standard heparin on trabecular bone in vivo
Muir, J., Andrew, M., Hirsh, J., Weitz, J., Young, E., Deschamps, P., & Shaughnessy, S. (1996) · Blood · doi:10.1182/blood.v88.4.1314.bloodjournal8841314 · Cited by 151
Edens, R. E., Al-Hakim, A. H., Weiler, J. M., Rethwisch, D. G., Fareed, J., & Linhardt, R. J. (1992) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600810821 · Cited by 150
Reversal of anticoagulants: an overview of current developments
Thiele, T., Selleng, K., & Greinacher, A. (2015) · Thrombosis and Haemostasis · doi:10.1160/th14-11-0982 · Cited by 150
Khorana, A. A., Sahni, A., Altland, O. D., & Francis, C. W. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000090671.56682.d7 · Cited by 149
Zacharski, L. R., & Ornstein, D. L. (1998) · PubMed · Cited by 149
A New Model for the Domain Structure of Heparan Sulfate Based on the Novel Specificity of K5 Lyase
Murphy, K. J., Merry, C. L. R., Lyon, M., Thompson, J. E., Roberts, I. S., & Gallagher, J. T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401774200 · Cited by 148
Binding affinities of vascular endothelial growth factor (VEGF) for heparin-derived oligosaccharides
Zhao, W., McCallum, S. A., Xiao, Z., Zhang, F., & Linhardt, R. J. (2011) · Bioscience Reports · doi:10.1042/bsr20110077 · Cited by 147
Production and Titering of Recombinant Adeno-associated Viral Vectors
McClure, C., Marshall-Phelps, K. L., Wulff, P., Klugmann, M., & Murray, A. (2011) · Journal of Visualized Experiments · doi:10.3791/3348 · Cited by 144
Perlecan regulates developmental angiogenesis by modulating the VEGF-VEGFR2 axis
Zoeller, J. J., Whitelock, J. M., & Iozzo, R. V. (2009) · Matrix Biology · doi:10.1016/j.matbio.2009.04.010 · Cited by 143
Slungaard, A., Vercellotti, G. M., Walker, G., Nelson, R. D., & Jacob, H. S. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.171.6.2025 · Cited by 142
Gómez‐Outes, A., Terleira‐Fernández, A. I., Lecumberri, R., Suárez‐Gea, M. L., & Vargas, E. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.06.020 · Cited by 141
Knappe, M., Bodevin, S., Selinka, H., Spillmann, D., Streeck, R. E., Chen, X. S., Lindahl, U., & Sapp, M. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705127200 · Cited by 139
Adeno-Associated Virus-2 and its Primary Cellular Receptor – Cryo-EM Structure of a Heparin Complex
O'Donnell, J. K., Taylor, K., & Chapman, M. (2009) · Virology · doi:10.1016/j.virol.2008.11.037 · Cited by 139
Heparin/Heparan Sulfate Biosynthesis
Carlsson, P., Presto, J., Spillmann, D., Lindahl, U., & Kjellén, L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801652200 · Cited by 139
Heparan sulfate-protein interactions: therapeutic potential through structure-function insights
Coombe, D. R., & Kett, W. C. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4293-7 · Cited by 139
Rönnberg, E., Melo, F. R., & Pejler, G. (2012) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155412458927 · Cited by 139
Fondaparinux for the treatment of patients with acute heparininduced thrombocytopenia
Finch, C. K., Howard, A. H., Minhas, S., & Lobo, B. (2007) · Thrombosis and Haemostasis · doi:10.1160/th07-04-0252 · Cited by 139
Diamant, Z., Timmers, M., van der Veen, H., Page, C. P., van der Meer, F. J., & Sterk, P. J. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.6.8665036 · Cited by 138
Self-citationFour Heparin Preparations: Anti-Xa Potentiating Effect of Heparin after Subcutaneous Injection
Johnson, E. A., Kirkwood, T. B. L., Stirling, Y., et al. (1976) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1648001 · Cited by 137
Feyzi, E., Lustig, F., Fager, G., Spillmann, D., Lindahl, U., & Salmivirta, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.9.5518 · Cited by 137
Dementiev, A., Petitou, M., Herbert, J., et al. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb810 · Cited by 137
Inhalable large porous microspheres of low molecular weight heparin: In vitro and in vivo evaluation
Rawat, A., Majumder, Q. H., & Ahsan, F. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.03.013 · Cited by 136
The effects of heparin and low molecular weight heparins on bone
Rajgopal, R., Bear, M., Butcher, M. K., & Shaughnessy, S. G. (2007) · Thrombosis Research · doi:10.1016/j.thromres.2006.10.025 · Cited by 135
Jose, P. J., Moss, I. K., Maini, R. N., & Williams, T. J. (1990) · Annals of the Rheumatic Diseases · doi:10.1136/ard.49.10.747 · Cited by 135
Kang, M. S., Alahmadi, M. D., Sawh, S. C., Kovacs, M. J., & Lazo‐Langner, A. (2014) · Blood · doi:10.1182/blood-2014-09-599498 · Cited by 134
Ariga, T., Miyatake, T., & Yu, R. K. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22393 · Cited by 134
Pégorier, S., Wagner, L. A., Gleich, G. J., & Pretolani, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4861 · Cited by 134
Fu, X., Chen, L., Li, J., Lin, M. S., You, H., & Wang, W. (2012) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2012.02.008 · Cited by 133
Perić-Hassler, L., Hansen, H. S., Baron, R., & Hünenberger, P. H. (2010) · Carbohydrate Research · doi:10.1016/j.carres.2010.05.026 · Cited by 133
Emerging role of serpinE2/protease nexin-1 in hemostasis and vascular biology
Bouton, M., Boulaftali, Y., Richard, B., Arocas, V., Michel, J., & Jandrot‐Perrus, M. (2012) · Blood · doi:10.1182/blood-2011-10-387464 · Cited by 133
Tryptophan within basic peptide sequences triggers glycosaminoglycan‐dependent endocytosis
Bechara, C., Manjula, P., Zaltsman, Y., Burlina, F., Alves, I. D., Lequin, O., & Sagan, S. (2012) · The FASEB Journal · doi:10.1096/fj.12-216176 · Cited by 132
Heparin Inhibits the Immediate Response to Antigen in the Skin and Lungs of Allergic Subjects
Bowler, S., Smith, S. M. S., & Lavercombe, P. S. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.1.160 · Cited by 131
Heparin-Induced Thrombocytopenia
Shantsila, E., Lip, G. Y. H., & Chong, B. H. (2009) · CHEST Journal · doi:10.1378/chest.08-2830 · Cited by 131
Oguma, T., Tomatsu, S., Montaño, A. M., & Okazaki, O. (2007) · Analytical Biochemistry · doi:10.1016/j.ab.2007.05.016 · Cited by 131
Inhibition of leucocyte elastase by heparin and its derivatives
Rédiní, F., Tixier, J. M., Petitou, M., et al. (1988) · Biochemical Journal · doi:10.1042/bj2520515 · Cited by 131
Inflammatory Cytokines and Fatty Acids Regulate Endothelial Cell Heparanase Expression
Chen, G., Wang, D., Vikramadithyan, R. K., Yagyu, H., Saxena, U., Pillarisetti, S., & Goldberg, I. J. (2004) · Biochemistry · doi:10.1021/bi0356552 · Cited by 130
Harris, E. N., Weigel, J. A., & Weigel, P. H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710360200 · Cited by 130
Shriver, Z. H., Sundaram, M., Venkataraman, G., Fareed, J., Linhardt, R. J., BIEMANN, K., & Sasisekharan, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.19.10365 · Cited by 129
Oral Delivery of Anticoagulant Doses of Heparin
Baughman, R., Kapoor, S. C., Agarwal, R., Kisicki, J. C., Catella-Lawson, F., & FitzGerald, G. A. (1998) · Circulation · doi:10.1161/01.cir.98.16.1610 · Cited by 129
Stevenson, J. L., Varki, A. P., & Borsig, L. (2007) · Thrombosis Research · doi:10.1016/s0049-3848(07)70138-x · Cited by 129
Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer
Akl, E. A., Kahale, L. A., Neumann, I., Barba, M., Sperati, F., Terrenato, I., Muti, P. C., & Schünemann, H. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006649.pub6 · Cited by 128
Heparin Inhibits Ligand Binding to the Leukocyte Integrin Mac-1 (CD11b/CD18)
Peter, K., Schwarz, M., Conradt, C., Nordt, T. K., Moser, M., Kübler, W., & Bode, C. (1999) · Circulation · doi:10.1161/01.cir.100.14.1533 · Cited by 126
Harmer, N. J., Pellegrini, L., Chirgadze, D., Fernández‐Recio, J., & Blundell, T. L. (2003) · Biochemistry · doi:10.1021/bi035320k · Cited by 126
Heparin Binding and Oligomerization of Hepatocyte Growth Factor/Scatter Factor Isoforms
Sakata, H., Stahl, S. J., Taylor, W. G., Rosenberg, J. M., Sakaguchi, K., Wingfield, P. T., & Rubin, J. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.14.9457 · Cited by 125
Zhu, M., Wang, K., Mei, J., Li, C., Zhang, J., Zheng, W., An, D., Xiao, N., Zhao, Q., Kong, D., et al. (2014) · Acta Biomaterialia · doi:10.1016/j.actbio.2014.01.022 · Cited by 125
Factor H and Atypical Hemolytic Uremic Syndrome
Józsi, M., Heinen, S., Hartmann, A., Ostrowicz, C. W., Hälbich, S., Richter, H., Kunert, A., Licht, C. P. B., Saunders, R. E., Perkins, S. J., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005080868 · Cited by 124
Giuffrè, L., Cordey, A.-S., Monai, N., Tardy, Y., Schapira, M., & Spertini, O. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.136.4.945 · Cited by 122
On‐line separations combined with MS for analysis of glycosaminoglycans
Zaia, J. (2008) · Mass Spectrometry Reviews · doi:10.1002/mas.20200 · Cited by 122
Crystal Structures of Novel Vascular Endothelial Growth Factors (VEGF) from Snake Venoms
Suto, K., Yamazaki, Y., Morita, T., & Mizuno, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411395200 · Cited by 121
Mallard Blue: A High-Affinity Selective Heparin Sensor That Operates in Highly Competitive Media
Bromfield, S. M., Barnard, A., Posocco, P., Fermeglia, M., Pricl, S., & Smith, D. K. (2013) · Journal of the American Chemical Society · doi:10.1021/ja311734d · Cited by 121
Forestier, F., Daffos, F., Rainaut, M., et al. (1987) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1651102 · Cited by 119
Capila, I., Hernáiz, M. J., Mo, Y., Mealy, T. R., Campos, B., Dedman, J. R., Linhardt, R. J., & Seaton, B. A. (2001) · Structure · doi:10.1016/s0969-2126(00)00549-9 · Cited by 118
Linhardt, R. J., Francis, J. L., Amirkhosravi, A., et al. (2006) · Thrombosis and Haemostasis · doi:10.1160/th06-05-0289 · Cited by 118
Action pattern of polysaccharide lyases on glycosaminoglycans
Jandik, K. A., Gu, K., & Linhardt, R. J. (1994) · Glycobiology · doi:10.1093/glycob/4.3.289 · Cited by 118
Analysis and characterization of heparin impurities
Béni, S., Limtiaco, J. F. K., & Larive, C. K. (2010) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-010-4121-x · Cited by 118
Actions of heparin that may affect the malignant process
Engelberg, H. (1999) · Cancer · Cited by 117
Generation of “Neoheparin” from E. coli K5 Capsular Polysaccharide
Lindahl, U., Li, J., Kusche‐Gullberg, M., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049812m · Cited by 117
Ornstein, D. L., & Zacharski, L. R. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615131 · Cited by 117
Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
Irie, A., Takami, M., Kubo, H., Sekino-Suzuki, N., Kasahara, K., & Sanai, Y. (2007) · Bone · doi:10.1016/j.bone.2007.04.190 · Cited by 116
Management of acute smoke inhalation injury
Toon, M. H., Maybauer, M. O., Greenwood, J. E., Maybauer, D. M., & Fraser, J. F. (2010) · Critical Care and Resuscitation · doi:10.1016/s1441-2772(23)01358-3 · Cited by 115
The temporal profile of the anti-PF4/heparin immune response
Greinacher, A., Kohlmann, T., Strobel, U., Sheppard, J. I., & Warkentin, T. E. (2008) · Blood · doi:10.1182/blood-2008-08-173062 · Cited by 115
Lietha, D., Chirgadze, D. Y., Mulloy, B., Blundell, T. L., & Gherardi, E. (2001) · The EMBO Journal · doi:10.1093/emboj/20.20.5543 · Cited by 114
Self-citationC1-Inhibitor: More Than a Serine Protease Inhibitor
Zeerleder, S. S. (2011) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0031-1276585 · Cited by 114
Weltermann, A., Philipp, K., Hafner, E., Kaider, A., Kittl, E.-M., Brenner, B., Mannhalter, C., Lechner, K., Kyrle, P. A., & Eichinger, S. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614366 · Cited by 113
Structural Basis of Oligosaccharide Receptor Recognition by Human Papillomavirus
Dasgupta, J., Bienkowska‐Haba, M., Ortega, M. E., Patel, H. D., Bodevin, S., Spillmann, D., Bishop, B., Sapp, M. J., & Chen, X. S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.160184 · Cited by 113
Release of Sequestered Malaria Parasites upon Injection of a Glycosaminoglycan
Vogt, A. M., Pettersson, F., Moll, K., Jonsson, C., Normark, J., Ribacke, U., Egwang, T. G., Ekre, H.-P. T., Spillmann, D., Chen, Q., et al. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020100 · Cited by 113
Cai, L., Zhan, R., Pu, K., Qi, X., Zhang, H., Huang, W., & Liu, B. (2011) · Analytical Chemistry · doi:10.1021/ac2016135 · Cited by 113
Heparan Sulfate Facilitates Rift Valley Fever Virus Entry into the Cell
de Boer, S. M., Kortekaas, J., de Haan, C. A. M., Rottier, P. J. M., Moormann, R. J. M., & Bosch, B. (2012) · Journal of Virology · doi:10.1128/jvi.01364-12 · Cited by 111
Heparin-induced anaphylactic and anaphylactoid reactions: two distinct but overlapping syndromes
Warkentin, T. E., & Greinacher, A. (2009) · Expert Opinion on Drug Safety · doi:10.1517/14740330902778180 · Cited by 111
Heparin binding induces conformational changes in Adeno-associated virus serotype 2
Levy, H. C., Bowman, V. D., Govindasamy, L., McKenna, R., Nash, K., Warrington, K., Chen, W., Muzyczka, N., Yan, X., Baker, T. S., et al. (2009) · Journal of Structural Biology · doi:10.1016/j.jsb.2008.12.002 · Cited by 110 · cited 3×
“The second study (Levy et al., 2009), using a partially depolymerized heparin, suffered the same problems, perhaps to a lesser extent; however, both studies agreed on the location of the major heparin binding site in the valleys between protrusions at the 3-fold axis of the icosahedral capsid.”
MethodResultAlban, S. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-23056-1_10 · Cited by 110
Low molecular weight heparin for the treatment of venous thromboembolism in pregnancy: a case series
Rodie, V. A., Thomson, A. J., Stewart, F. M., Quinn, A. J., Walker, I. D., & Greer, I. A. (2002) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2002.01525.x · Cited by 110
IL-12 Is a Heparin-Binding Cytokine
Hasan, M., Najjam, S., Gordon, M. Y., Gibbs, R. V., & Rider, C. C. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.2.1064 · Cited by 109
Fryer, A. D., Huang, Y.-C. T., Rao, G. V., Jacoby, D. B., Mancilla, E., Whorton, R., Piantadosi, C. A., Kennedy, T. P., & Hoidal, J. R. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36816-8 · Cited by 109
Skop, N. B., Calderón, F. H., Levison, S. W., Gandhi, C. D., & Cho, C. H. (2013) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.02.043 · Cited by 109
Harmer, N. J., Ilag, L. L., Mulloy, B., Pellegrini, L., Robinson, C. V., & Blundell, T. L. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.04.031 · Cited by 109
Self-citationMoon, A. F., Edavettal, S. C., Krahn, J. M., Muñoz, E. M., Negishi, M., Linhardt, R. J., Liu, J., & Pedersen, L. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405013200 · Cited by 109
Fucosylated Chondroitin Sulfates from the Body Wall of the Sea Cucumber Holothuria forskali
Panagos, C. G., Thomson, D., Moss, C., Hughes, A. D., Kelly, M. S., Liu, Y., Chai, W., Venkatasamy, R., Spina, D., Page, C. P., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.572297 · Cited by 108
Self-citationAntimetastatic activities of heparins and modified heparins. Experimental evidence
Borsig, L. (2010) · Thrombosis Research · doi:10.1016/s0049-3848(10)70017-7 · Cited by 108
Lever, R., Hoult, J. R. S., & Page, C. P. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703099 · Cited by 108
Self-citationIdentification of a Glycosaminoglycan-binding Site in Chemokine Macrophage Inflammatory Protein-1α
Koopmann, W., & Krangel, M. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.15.10103 · Cited by 106
Eggert, S., Midthune, B., Cottrell, B. A., & Koo, E. H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.038646 · Cited by 106
Crystallographic Analysis of Calcium-dependent Heparin Binding to Annexin A2
Shao, C., Zhang, F., Kemp, M. M., Linhardt, R. J., Waisman, D. M., Head, J. W., & Seaton, B. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604502200 · Cited by 106
Watterson, D., Kobe, B., & Young, P. R. (2011) · Journal of General Virology · doi:10.1099/vir.0.037317-0 · Cited by 106
Shaw, J. P., Johnson, Z., Borlat, F., Zwahlen, C., Kungl, A. J., Roulin, K., Harrenga, A., Wells, T. N. C., & Proudfoot, A. E. I. (2004) · Structure · doi:10.1016/j.str.2004.08.014 · Cited by 105
Structural insights into proteoglycan-shaped Hedgehog signaling
Whalen, D. M., Malinauskas, T., Gilbert, R. J. C., & Siebold, C. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310097110 · Cited by 105
Tanino, Y., Coombe, D. R., Gill, S. E., Kett, W. C., Kajikawa, O., Proudfoot, A. E. I., Wells, T. N. C., Parks, W. C., Wight, T. N., Martin, T. R., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903274 · Cited by 105
YU, H., MUNOZ, E., Edens, R. E., & Linhardt, R. J. (2005) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2005.08.003 · Cited by 105
Role of heparan sulfate domain organization in endostatin inhibition of endothelial cell function
Kreuger, J., Matsumoto, T., Vanwildemeersch, M., Sasaki, T., Timpl, R., Claesson, L., Spillmann, D., & Lindahl, U. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf638 · Cited by 104
Cifonelli, J. A., & Dorfman, A. (1962) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(62)90141-9 · Cited by 104
Parenteral anticoagulation in ambulatory patients with cancer
Akl, E. A., Kahale, L. A., Hakoum, M. B., Matar, C. F., Sperati, F., Barba, M., Yosuico, V. E. D., Terrenato, I., Synnot, A., & Schünemann, H. J. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006652.pub5 · Cited by 104
Unfractionated Heparin for Hemodialysis: Still the Best Option
Cronin, R. E., & Reilly, R. F. (2010) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2010.00770.x · Cited by 103
Heparin-modified gelatin scaffolds for human corneal endothelial cell transplantation
Niu, G., Choi, J.-S., Wang, Z., Skardal, A., Giegengack, M., & Söker, S. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.01.033 · Cited by 103
Bilayered vascular grafts based on silk proteins
Liu, S., Chaofei, D., Lu, G., Lü, Q., Li, Z., Kaplan, D. L., & Zhu, H. (2013) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.06.045 · Cited by 103
Hu, Y., Zhong, Y., Chen, Z., Chen, C., Shi, Z., Zulueta, M. M. L., Ku, C., Lee, P.-Y., Wang, C., & Hung, S. (2012) · Journal of the American Chemical Society · doi:10.1021/ja3090065 · Cited by 103
The Inhibitory Effect of Heparin and Related Glycosaminoglycans on Neutrophil Chemotaxis
Matzner, Y., Marx, G. S., Drexler, R., & Eldor, A. (1984) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1661157 · Cited by 102
Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients
Kanaan, A. O., Silva, M. A., Donovan, J. L., Roy, T., & Al‐Homsi, A. S. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.11.015 · Cited by 102
Mulloy, B., Forster, M. J., Jones, C., Drake, A. F., Johnson, E. A., & Davies, D. B. (1994) · Carbohydrate Research · doi:10.1016/s0008-6215(00)90968-6 · Cited by 101
Self-citationPrediction of heparin binding sites in bone morphogenetic proteins (BMPs)
Gandhi, N. S., & Mancera, R. L. (2012) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2012.07.002 · Cited by 101
Pomin, V. H. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.08.022 · Cited by 101
Meta‐analysis: the utility and safety of heparin in the treatment of active ulcerative colitis
Shen, J., Ran, Z. H., TONG, J. L., & XIAO, S. D. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03418.x · Cited by 100
Lensing, A. W. A., Prins, M. H., Pesavento, R., Piccioli, A., Sartori, M., Tormene, D., Milan, M., Vedovetto, V., Noventa, F., Villalta, S., et al. (2015) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0035-1544161 · Cited by 100
Crublet, E., Andrieu, J., Vivès, R. R., & Lortat‐Jacob, H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800066200 · Cited by 99
Kamphuisen, P. W., & Agnelli, G. (2006) · Thrombosis Research · doi:10.1016/j.thromres.2006.03.010 · Cited by 99
Heparin Characterization: Challenges and Solutions
Jones, C. J., Béni, S., Limtiaco, J. F. K., Langeslay, D. J., & Larive, C. K. (2011) · Annual Review of Analytical Chemistry · doi:10.1146/annurev-anchem-061010-113911 · Cited by 99
Fibroblast growth factors share binding sites in heparan sulphate
Kreuger, J., Jemth, P., SANDERS-LINDBERG, E., Eliahu, L., Ron, D., Basilico, C., Salmivirta, M., & Lindahl, U. (2005) · Biochemical Journal · doi:10.1042/bj20042129 · Cited by 98
Nagamine, S., Tamba, M., Ishimine, H., Araki, K., Shiomi, K., Okada, T., Ohto, T., Kunita, S., Takahashi, S., Wismans, R. G., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.290262 · Cited by 98
Ramamurthy, N., Baliga, N., Wahr, J. A., Schaller, U., Yang, V. C.-M., & Meyerhoff, M. E. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.3.606 · Cited by 98
Doneanu, C. E., Chen, W., & Gebler, J. C. (2009) · Analytical Chemistry · doi:10.1021/ac802770r · Cited by 97
Bertini, S., Bisio, A., Torri, G., et al. (2004) · Biomacromolecules · doi:10.1021/bm049693s · Cited by 97
Basche, M., Gustafson, D. L., Holden, S. N., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2423 · Cited by 97
Johnson, D. J. D., Langdown, J., & Huntington, J. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910144107 · Cited by 97
Nader, H. B., Lopes, C. C., Rocha, H. A. O., dos Santos, E. A., & Dietrich, C. P. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043452758 · Cited by 96
Akl, E. A., van Doormaal, F. F., Barba, M., et al. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006652 · Cited by 95
Beinrohr, L., Harmat, V., Dobó, J., Lőrincz, Z., Gál, P., & Závodszky, P. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700841200 · Cited by 95
Neumann, I., Rada, G., Claro, J. C., Carrasco-Labra, A., Thorlund, K., Akl, E. A., Bates, S. M., & Guyatt, G. H. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-10-201205150-00421 · Cited by 94
Bleeding complications during anticoagulant treatment in patients with cancer
Kamphuisen, P. W., & Beyer‐Westendorf, J. (2014) · Thrombosis Research · doi:10.1016/s0049-3848(14)50009-6 · Cited by 94
Chiodelli, P., Mitola, S. M. F., Ravelli, C., Oreste, P., Rusnati, M., & Presta, M. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.235184 · Cited by 94
The Structural Biology of the FGF19 Subfamily
Beenken, A., & Mohammadi, M. (2012) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4614-0887-1_1 · Cited by 93
Samoszuk, M. K., Kanakubo, E., & Chan, J. K. (2005) · BMC Cancer · doi:10.1186/1471-2407-5-121 · Cited by 93
Low molecular weight heparin in pregnancy: current issues
Greer, I. A., & Hunt, B. J. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05304.x · Cited by 93
Near-Atomic Resolution Cryo-Electron Microscopic Structure of Dengue Serotype 4 Virus
Kostyuchenko, V. A., Chew, P. L., Ng, T., & Lok, S. (2013) · Journal of Virology · doi:10.1128/jvi.02641-13 · Cited by 92
Diagnosis, Treatment, and Prevention of Venous Thromboembolism in Pregnancy
Marshall, A. L. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.11.2830 · Cited by 91
Xiao, Z., Visentin, G. P., Dayananda, K. M., & Neelamegham, S. (2008) · Blood · doi:10.1182/blood-2008-04-153288 · Cited by 91
Bitomsky, W., & Wade, R. C. (1999) · Journal of the American Chemical Society · doi:10.1021/ja983319g · Cited by 91
Characterization of specific receptors for vasopressin in the pituitary gland
Lutz‐Bucher, B., & Koch, B. (1983) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(83)80171-5 · Cited by 91
Molecular Mapping and Functional Characterization of the VEGF164 Heparin-binding Domain
Krilleke, D., DeErkenez, A., Schubert, W., Giri, I., Robinson, G. S., Ng, Y., & Shima, D. T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700319200 · Cited by 91
Bioactive technologies for hemocompatibility
Tanzi, M. C. (2005) · Expert Review of Medical Devices · doi:10.1586/17434440.2.4.473 · Cited by 91
Conformational equilibria of α-L-iduronate residues in disaccharides derived from heparin
Sanderson, P. N., Huckerby, T. N., & Nieduszynski, I. A. (1987) · Biochemical Journal · doi:10.1042/bj2430175 · Cited by 91
Marchetti, M., Vignoli, A., Russo, L., Balducci, D., Pagnoncelli, M., Barbui, T., & Falanga, A. (2007) · Thrombosis Research · doi:10.1016/j.thromres.2007.06.015 · Cited by 90
Anti-Xa active heparin oligosaccharides
Choay, J., Lormeau, J. C., Petitou, M., Sînaÿ, P., Casu, B., Oreste, P., Torri, G., & Gatti, G. (1980) · Thrombosis Research · doi:10.1016/0049-3848(80)90356-4 · Cited by 90
Zhang, Z., Xie, J., Liu, H., Liu, J., & Linhardt, R. J. (2009) · Analytical Chemistry · doi:10.1021/ac9001707 · Cited by 90
Rhomberg, A. J., Ernst, S., Sasisekharan, R., & BIEMANN, K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4176 · Cited by 90
Effects of Heparin on Lipoprotein Lipase from Bovine Milk
Iverius, P., Lindahl, U., Egelrud, T., & Olivecrona, T. (1972) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)44735-2 · Cited by 89
Fondaparinux: does it cause HIT? can it treat HIT?
Warkentin, T. E. (2010) · Expert Review of Hematology · doi:10.1586/ehm.10.54 · Cited by 89
Schwörer, R., Zubkova, O. V., Turnbull, J. E., & Tyler, P. C. (2013) · Chemistry - A European Journal · doi:10.1002/chem.201204519 · Cited by 89
The Effects of Unfractionated Heparin on Survival in Patients with Malignancy – A Systematic Review
Smorenburg, S. M., Hettiarachchi, R., Vink, R., & Büller, H. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614885 · Cited by 89
Koopmann, W., Ediriwickrema, C., & Krangel, M. S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.4.2120 · Cited by 89
Sheng, J., Liu, R., Xu, Y., & Liu, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.224311 · Cited by 88
Théry, C., Simonneau, G., Meyer, G., Hélénon, O., Bridey, F., Armagnac, C., d’Azemar, P., & Coquart, J.-P. (1992) · Circulation · doi:10.1161/01.cir.85.4.1380 · Cited by 88
Cook, D., Douketis, J. D., Meade, M. O., Guyatt, G. H., Zytaruk, N. L., Granton, J. T., Skrobik, Y. K., Albert, M., Fowler, R., Hébert, P. C., et al. (2008) · Critical Care · doi:10.1186/cc6810 · Cited by 88
Carlson, M. K., Gleason, P. P., & Sen, S. (2001) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.21.1.108.34436 · Cited by 88
Inhibition of leukocyte rolling in venules by protamine and sulfated polysaccharides
Tangelder, G., & Arfors, K. (1991) · Blood · doi:10.1182/blood.v77.7.1565.1565 · Cited by 88
Vivès, R. R., Sadir, R., Imberty, A., Rencurosi, A., & Lortat‐Jacob, H. (2002) · Biochemistry · doi:10.1021/bi026459i · Cited by 87
Tan, K., Duquette, M. A., Liu, J., Zhang, R., Joachimiak, A., Wang, J., & Lawler, J. (2006) · Structure · doi:10.1016/j.str.2005.09.017 · Cited by 87
Kailemia, M. J., Li, L., Ly, M., Linhardt, R. J., & Amster, I. J. (2012) · Analytical Chemistry · doi:10.1021/ac3015824 · Cited by 86
Processing of Macromolecular Heparin by Heparanase
Gong, F., Jemth, P., Galvis, M. L. E., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300925200 · Cited by 85
Inhibition of delayed-type hypersensitivity by heparin depleted of anticoagulant activity
Sy, M. S., Schneeberger, E. E., McCluskey, R., Greene, M. I., ROSENBERG, R. D., & D, B. B. M. (1983) · Cellular Immunology · doi:10.1016/0008-8749(83)90137-5 · Cited by 85
Chemokine-Glycosaminoglycan Binding
Yu, Y., Sweeney, M. D., Saad, O. M., Crown, S. E., Handel, T. M., & Leary, J. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505738200 · Cited by 84
Shriver, Z. H., Raman, R., Venkataraman, G., Drummond, K., Turnbull, J. E., Toida, T., Linhardt, R. J., BIEMANN, K., & Sasisekharan, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.19.10359 · Cited by 83
Koopmann, W., Ediriwickrema, C., & Krangel, M. S. (1999) · PubMed · Cited by 83
Gralle, M., Oliveira, C. L. P., Guerreiro, L. H., McKinstry, W. J., Galatis, D., Masters, C. L., Cappai, R., Parker, M. W., Ramos, C. H. I., Torriani, I. L., et al. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.12.053 · Cited by 82
Vanpouille, C., Deligny, A., Delehedde, M., Denys, A., Melchior, A., Liénard, X., Lyon, M., Mazurier, J., Fernig, D. G., & Allain, F. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701835200 · Cited by 81
NMR structure of the Wnt modulator protein Sclerostin
Weidauer, S. E., Schmieder, P., Beerbaum, M., Schmitz, W., Oschkinat, H., & Mueller, T. D. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.01.062 · Cited by 81
Cited by
Shi, D., Beasock, D., Fessler, A., Szebeni, J., Ljubimova, J. Y., Afonin, K. A., & Dobrovolskaia, M. A. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114079 · Cited by 535
Gritsch, L., Conoscenti, G., La Carrubba, V., Nooeaid, P., & Boccaccini, A. R. (2019) · Materials Science and Engineering: C · doi:10.1016/j.msec.2018.09.038 · Cited by 51
Metadata
- Authors
- Mulloy, B., Hogwood, J., Gray, E., Lever, R., & Page, C. P.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2016-01
- Volume
- 68
- Issue
- 1
- Pages
- 76-141
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2212792660
- Cited by
- 341
- References
- 687
- FWCI
- 8.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.